| Mr John Steven Brunson, RPH | |
|
2020 Roseland Blvd, Tyler, TX 75701-4248 | |
| (903) 597-1358 | |
| Not Available |
| Full Name | Mr John Steven Brunson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2020 Roseland Blvd, Tyler, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124644141 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 23663 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr John Steven Brunson, RPH 1347 Santa Fe Trl, Tyler, TX 75703-0414 Ph: (409) 673-4607 | Mr John Steven Brunson, RPH 2020 Roseland Blvd, Tyler, TX 75701-4248 Ph: (903) 597-1358 |
News Archive
An Ohio Federal Court of Appeals ruling issued yesterday is reinstating the late victim's claim that the recalled diet drug Redux (commonly called fen-phen) linked to her death should never have been marketed to the American people by Wyeth due in part to its pre-approval concerns about potentially lethal side effects.
A training tool that helps physicians involve patients in decision-making can reduce the use of antibiotics for acute respiratory infections, according to a study published in CMAJ (Canadian Medical Association Journal).
Long-term studies on prevention, behavior, and other priorities like integrated scientific research and education are needed to solve the global obesity epidemic according to scientists focused on remedying this pressing health problem.
Acetylon Pharmaceuticals Inc. today announced that it has been granted U.S. Patent 8,148,526 by the United States Patent and Trademark Office (USPTO). This patent contains fundamental composition of matter claims covering the Company's selective HDAC6 inhibitor, ACY-1215, which is currently being investigated in human clinical trials for the treatment of multiple myeloma.
iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company has signed a collaboration development agreement with The Consortium for Parasitic Drug Development (CPDD) for the research and development of iCo's oral drug delivery technology for the treatment of neglected diseases such as leishmaniasis and trypanosomiasis. Initial funding of USD $182,930 will be provided for formulation optimization for tropical conditions.
› Verified 1 days ago
Kymberli Bell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5976 Old Jacksonville Hwy, Tyler, TX 75703 Phone: 903-405-6215 Fax: 903-405-6212 | |
Dr. Merideth Chavez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1702 S Broadway Ave, Tyler, TX 75701 Phone: 903-526-8183 | |
Patricia Dianne Shackelford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7088 Fax: 903-877-7006 | |
Juan Eduardo Loy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1105 E Gentry Pkwy, Tyler, TX 75702 Phone: 903-535-9467 | |
Sarah Kang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5415 S Broadway Ave, Tyler, TX 75703 Phone: 909-938-9298 | |
Dr. Billy Joe Sartor, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11937 Us Highway 271, University Of Texas Health Center At Tyler, Tyler, TX 75708 Phone: 903-877-7096 Fax: 903-877-7006 | |
Payton Elizabeth Hightower, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 703 S Fleishel Ave Ste 4000, Tyler, TX 75701 Phone: 903-606-3000 |